Karnataka Pushes for Wider Price Caps on High-Cost Life-Saving Drugs
Karnataka Health Minister U.T. Khader has urged the Union government to extend price rationalisation beyond cancer medicines to other high-cost, life-saving drugs, arguing that regulatory relief must translate into direct savings for patients. His remarks add momentum to a broader policy debate over how India should balance access, affordability and pharmaceutical pricing in essential care.
